Total Payments
$5,187
2024 Payments
$2,182
Companies
44
Transactions
273
Medicare Patients
675
Medicare Billing
$63,405
Payment Breakdown by Category
Food & Beverage$4,592 (88.5%)
Research$500.00 (9.6%)
Education$94.99 (1.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,592 | 271 | 88.5% |
| Unspecified | $500.00 | 1 | 9.6% |
| Education | $94.99 | 1 | 1.8% |
Payments by Type
General
$4,687
272 transactions
Research
$500.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lucid Diagnostics Inc. | $538.82 | 4 | $0 (2023) |
| Lilly USA, LLC | $437.61 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $412.67 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $333.14 | 16 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $300.19 | 10 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $282.52 | 16 | $0 (2024) |
| Amgen Inc. | $279.17 | 19 | $0 (2024) |
| ABBVIE INC. | $253.43 | 18 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $231.43 | 12 | $0 (2024) |
| GlaxoSmithKline, LLC. | $229.82 | 15 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,182 | 121 | Astellas Pharma US Inc ($323.77) |
| 2023 | $2,458 | 116 | Lucid Diagnostics Inc. ($513.02) |
| 2022 | $531.74 | 35 | Bayer HealthCare Pharmaceuticals Inc. ($62.21) |
| 2021 | $15.31 | 1 | AbbVie Inc. ($15.31) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: RESPIRATORY | ||||||
| 12/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.91 | General |
| Category: Neuroscience | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/18/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $94.99 | General |
| 11/18/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Edwards Lifesciences Corporation | EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) (Device) | Food and Beverage | In-kind items and services | $22.87 | General |
| Category: Transcatheter Heart Valves | ||||||
| 11/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Neuropsychiatry | ||||||
| 11/11/2024 | Daiichi Sankyo Inc. | INJECTAFER (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Iron Deficiency Anemia | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Respiratory | ||||||
| 11/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Biological | ||||||
| 10/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.52 | General |
| Category: Diabetes Care | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $21.67 | General |
| Category: Biological | ||||||
| 10/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: VACCINE | ||||||
| 10/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), SYNJARDY | Food and Beverage | In-kind items and services | $23.19 | General |
| Category: DIABETES | ||||||
| 10/08/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Biological | ||||||
| 09/18/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Clinical Utility of a Non endoscopic Device EsoCheck and Biomarker EsoGuard as Alternative to Endoscopy for Screening for Barretts Esophagus in At Risk Population (ASBE) A Randomized Controlled, Virtual Patient Trial | Lucid Diagnostics Inc. | $500.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 416 | 591 | $85,670 | $40,439 |
| 2022 | 8 | 259 | 306 | $40,970 | $22,966 |
Total Patients
675
Total Services
897
Medicare Billing
$63,405
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 186 | 320 | $56,000 | $25,926 | 46.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 35 | 35 | $7,700 | $4,290 | 55.7% |
| 99483 | Assessment of and care planning for patient with impaired thought processing, typically 60 minutes | Office | 2023 | 17 | 20 | $6,200 | $3,572 | 57.6% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 28 | 28 | $2,800 | $2,047 | 73.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 29 | 29 | $5,800 | $1,583 | 27.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 33 | 33 | $1,320 | $938.56 | 71.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 11 | 13 | $1,885 | $668.14 | 35.4% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 13 | 15 | $1,950 | $541.28 | 27.8% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 12 | 12 | $600.00 | $486.60 | 81.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $480.00 | $277.44 | 57.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 23 | $230.00 | $78.43 | 34.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 13 | 47 | $705.00 | $31.70 | 4.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 143 | $25,025 | $13,746 | 54.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $6,820 | $3,850 | 56.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 22 | $3,190 | $1,535 | 48.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 19 | 19 | $1,900 | $1,335 | 70.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 28 | 29 | $1,450 | $1,176 | 81.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 20 | 20 | $800.00 | $557.20 | 69.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 25 | 27 | $810.00 | $437.94 | 54.1% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 15 | 15 | $975.00 | $329.55 | 33.8% |
About Dr. William Draper, DO
Dr. William Draper, DO is a Family Medicine healthcare provider based in Bountiful, Utah. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2019. The National Provider Identifier (NPI) number assigned to this provider is 1053978387.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Draper, DO has received a total of $5,187 in payments from pharmaceutical and medical device companies, with $2,182 received in 2024. These payments were reported across 273 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,592).
As a Medicare-enrolled provider, Draper has provided services to 675 Medicare beneficiaries, totaling 897 services with total Medicare billing of $63,405. Data is available for 2 years (2022–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bountiful, UT
- Active Since 05/22/2019
- Last Updated 09/12/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053978387
Products in Payments
- Veozah (Drug) $317.68
- REXULTI (Drug) $316.28
- SPRAVATO (Drug) $300.19
- MOUNJARO (Drug) $250.97
- Otezla (Drug) $216.56
- SHINGRIX (Biological) $184.04
- TRADJENTA (Drug) $177.90
- Kerendia (Drug) $167.37
- AIRSUPRA (Drug) $159.66
- JARDIANCE (Drug) $152.90
- VRAYLAR (Drug) $142.74
- GEMTESA (Drug) $137.00
- Korlym (Drug) $117.27
- INJECTAFER (Drug) $101.36
- NURTEC ODT (Drug) $85.85
- LEQVIO (Drug) $75.26
- QUVIVIQ (Drug) $73.07
- QULIPTA (Drug) $64.41
- Repatha (Biological) $62.61
- RYTARY (Drug) $58.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bountiful
Scott Erickson
Family Medicine — Payments: $135,999
Family Medicine $135,999
Allen Freestone, Md, MD
Family Medicine — Payments: $9,138
Family Medicine $9,138
David Cope, Md, MD
Family Medicine — Payments: $6,614
Family Medicine $6,614
Dr. Antonina Callahan, Md, MD
Family Medicine — Payments: $4,441
Family Medicine $4,441
Dr. Brian Rodgers, D. O, D. O
Family Medicine — Payments: $4,368
Family Medicine $4,368
Allison Hanna, D.o, D.O
Family Medicine — Payments: $2,662
Family Medicine $2,662